STOCK TITAN

BriaCell Therapeutics Corp. Warrant (BCTXW) Net Income by Year

BCTXW

BriaCell Therapeutics Corp. Warrant reported a net loss of $26.3M in fiscal year 2025. This represents a decrease of 449.1% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters BriaCell Therapeutics Corp. Warrant has filed alongside them.

FY2025 annual
Net Income -$26.3M
YoY -449.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jan 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BCTXW Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21
Net Income-$26.3M-449.1%-$4.8M+76.4%-$20.3M+24.4%-$26.8M-94.3%-$13.8M

BCTXW Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'25Q2'2510-QQ1'2510-QQ4'2410-KQ3'24Q2'24Q1'24Q4'23Q3'23
Net Income-$7.2M-14.8%-$8.2M-41.3%N/A-$6.1M-457.1%-$6.3M+44.3%-$5.8M-196.7%N/A$1.7M+135.0%-$11.3M+4.9%$6.0M+642.4%N/A-$4.9M+51.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More BriaCell Therapeutics Corp. Warrant financials

Frequently Asked Questions

What was BriaCell Therapeutics Corp. Warrant's net income in fiscal year 2025?

BriaCell Therapeutics Corp. Warrant reported a net loss of $26.3M in fiscal year 2025.

How fast is BriaCell Therapeutics Corp. Warrant's net income growing?

BriaCell Therapeutics Corp. Warrant (BCTXW) net income fell by 449.1% year over year, from -$4.8M to -$26.3M in fiscal year 2025.

How has BriaCell Therapeutics Corp. Warrant's net income changed over the years?

Across the 5 fiscal years this page covers, BriaCell Therapeutics Corp. Warrant (BCTXW) net income went from -$13.8M in fiscal year 2021 to -$26.3M in fiscal year 2025.

BriaCell Therapeutics Corp. Warrant (BCTXW) reported -$7.2M in net income in Q2 2026. This represents a decrease of 14.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what BriaCell Therapeutics Corp. Warrant (BCTXW) reported on that line in every period on record.